ELI LILLY Updates Holdings in AC Immune - Nasdaq

ELIS Stock  EUR 19.26  0.09  0.47%   
About 62% of Elis SA's investor base is looking to short. The analysis of current outlook of investing in Elis SA suggests that many traders are alarmed regarding Elis SA's prospects. The current market sentiment, together with Elis SA's historical and current headlines, can help investors time the market. In addition, many technical investors use Elis SA stock news signals to limit their universe of possible portfolio assets.
  
ELI LILLY Updates Holdings in AC Immune Nasdaq

Read at news.google.com
Google News at Macroaxis
  

Elis SA Fundamental Analysis

We analyze Elis SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elis SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elis SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Elis SA is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Elis SA Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elis SA stock to make a market-neutral strategy. Peer analysis of Elis SA could also be used in its relative valuation, which is a method of valuing Elis SA by comparing valuation metrics with similar companies.

Complementary Tools for Elis Stock analysis

When running Elis SA's price analysis, check to measure Elis SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elis SA is operating at the current time. Most of Elis SA's value examination focuses on studying past and present price action to predict the probability of Elis SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elis SA's price. Additionally, you may evaluate how the addition of Elis SA to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world